Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cudetaxestat - Blade Therapeutics

Next Previous
X
Search
Drug Profile

Cudetaxestat - Blade Therapeutics

Alternative Names: BLD-0409; PAT 409

Latest Information Update: 28 Jun 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PharmAkea Therapeutics
  • Developer Blade Therapeutics
  • Class Anti-inflammatories; Antifibrotics; Benzoic acids; Halogenated hydrocarbons; Hepatoprotectants; Indoles; Organic sulfur compounds; Pyrazoles; Skin disorder therapies; Small molecules; Urologics
  • Mechanism of Action ENPP2 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic pulmonary fibrosis; Systemic scleroderma
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Idiopathic pulmonary fibrosis
  • Phase I Liver disorders; Systemic scleroderma
  • Discontinued Cholangitis; Inflammatory bowel diseases; Kidney disorders; Non-alcoholic steatohepatitis; Scleroderma

Most Recent Events

  • 28 Jun 2024 No recent reports of development identified for phase-I development in Idiopathic-pulmonary-fibrosis(In volunteers) in Australia (PO, Liquid)
  • 28 Jun 2024 No recent reports of development identified for phase-I development in Idiopathic-pulmonary-fibrosis(In volunteers) in Australia (PO, Tablet)
  • 08 Feb 2023 3756390: kdm updated, PD data/AE data updated, HEs added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top